Swedish Orphan Biovitrum: A Rare Disease Company Undervalued By 20% Seeking Alpha, 28 Jun 2020 Swedish Orphan Biovitrum (STO:SOBI) (OTC: OTCPK:BIOVF ) is a USD 6.2B Swedish biopharmaceutical company engaged in the research…